Plasma gelatinase activity and PMN elastase concentration in patients with acute non-lymphoid leukaemia and chronic myelogenous leukaemia;Aktywność zelatynaz i stezenie elastazy granulocytów w osoczu chorych na ostra białazczke nielimfoblastyczna i na przewlekła białaczke szpikowa

Advances in Clinical and Experimental Medicine

Volumn 12, Issue 3, 2003, Pages 289-295

  Kornaszewska, Aneta ^a   Urbaniak, Joanna ^a   Nowicka, Jadwiga ^b   Woźniak, Mieczysław ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Nowotworow Krwi Transp Szpiku AM   (Poland)

Author keywords

Elastase; Gelatinase; Leukaemia

Indexed keywords

ALPHA 1 ANTITRYPSIN; EDETIC ACID; GELATINASE; GELATINASE A; GELATINASE B; LEUKOCYTE ELASTASE;

ACUTE NONLYMPHOCYTIC LEUKEMIA; ARTICLE; CELL GRANULE; CELL MATURATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COMPLEX FORMATION; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; LEUKOCYTE DIFFERENTIAL COUNT; MALE; NEUTROPHIL; RANK SUM TEST; STATISTICAL ANALYSIS; ZYMOGRAPHY;

EID: 0038688443     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Liou T. G., Campbell E. J.: Nonisotopic enzyme-inhibitor interactions: a novel nonoxidative mechanism for quantum proteolysis by human neutrophils. Biochemistry 1995, 22, 3714-3720.
2. Murphy G., Reynolds J. J.: Extracellular matrix degradation. In: Connective Tissue and its Heritable Disorders. Eds.: Royce P. M., Steinmann B. Wiley-Liss, New York 1993, 287-316.
3. Hastka J.: The importance of granulocyte elastase in haematological diagnosis. Blut 1988, 57, 69-75.
4. Pugin J., Widmer M. C., Kossodo S., Liang C. M.: Human neutrophils secrete gelatinase B in vitro in response to endotoxin and proinflammatory mediators. Am. J. Res. Cell. Mol. Biol. 1999, 20, 458-464.
5. Szwartz J. D., Monea S., Marcus S. G., Patel S., Eng K., Galloway A. C., Mignati P., Shamamian P.: Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2. J. Surg. Res. 1998, 76, 79-85.
6. Borregard N., Cowland J. B.: Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997, 89, 3503-3521.
7. Roszkowska-Jakimiec W., Worowska A., Gacko M., Maksimowicz T.: Proteazy granulocytów obojetnochłonnych. Post. Hig. Med. Dośw. 2002, 56, 73-92.
8. Wysocka J., Lipartowska R., Lipska A.: Ziarnistości granulocytów obojetnochłonnych. Post. Hig. Med. Dośw. 2001, 55, 177-188.
9. Johansson N., Ahonen M., Kahari V. M.: Matrix metalloproteinases in tumor invasion. Cell. Mol. Life Sci. 2000, 57, 5-15.
10. Gianelli G., Antonaci S.: Gelatinases and their inhibitors in human metastasis: from biological research to medical applications. Histol. Histopathol. 2002, 17, 339-345.
11. Barille S., Akhoundi C., Collette M., Mellerin M. P., Rapp M. J., Harousseau J. L., Bataille R., Amiot M.: Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells. Blood 1997, 90, 1649-1655.
12. Ries C., Loher F., Zang C., Ismair M. G., Petrides P. E.: Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Clin. Cancer Res. 1999, 5, 1115-1124.
13. Kuittinen O., Savolainen E. R., Koistinen P., Turpeenniemi-Hujanen T.: Gelatinase A and B (MMP-2, MMP-9) in leukaemia MMP-2 may indicate a good prognosis in AML. Anticancer Res. 1999, 19 (5C), 4395-4400.
14. Ismair M. G., Ries C., Petrides P. E.: Matrix metalloproteinases and their inhibitors in acute myeloid leukemia. Leukemia 1997, 11, 527-529.
15. Janowska-Wieczorek A., Marquez L. A., Matsuzaki A., Hashmi H. R., Larratt L. M., Boshkov L. M., Turner A. R., Zhang M. C., Edwards D. R., Kossakowska A. E.: Expression of matrix metalloproteinases (MMP-2 and MMP-9) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells. Br. J. Haematol. 1999, 105, 402-411.
16. Kleiner D. E., Stetler-Stevenson W. G.: Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem. 1994, 218, 325-329.
17. Matsuzaki A., Janowska-Wieczorek A.: Unstimulated human acute myelogenous leukemia blasts secrete matrix metalloproteinases. J. Cancer Res. Clin. Oncol. 1997, 123, 100-106.
18. Nellisen I., Ronsse I., Van Damme J., Opdenakker G.: Regulation of gelatinase B in human monocytic and endothelial cells by PECAM-1 ligation and its modulation by interferon-beta. J. Leukocyte Biol. 2002, 71, 89-98.
19. Sawicki G., Matsuzaki A., Janowska-Wieczorek A.: Expression of active form of MMP-2 on the surface of leukemic cells accounts for their in vitro invasion. J. Cancer Res. Clin. Oncol. 1998, 124, 245-252.
20. Janiak M., Hashmi H. R., Janowska-Wieczorek A.: Use of the Matrigel-based assay to measure the invasiveness of leukemic cells. Exp. Hematol. 1994, 22, 559-565.